Autopsy report · NCT06575686

Epcoritamab and Tazemetostat for the Treatment of Relapsed or Refractory Grade I-IIIa Follicular Lymphoma

“Pending Interim Analysis”

The sponsor’s own words in the registry.

Life of this trial

• Registered 7 months before it started.
• Suspended: paused, and may or may not restart.
• 33 participants planned (an estimate, not an actual count).

Vital statistics

Status

Suspended

Phase

Phase 2

Sponsor

City of Hope Medical Center

Sponsor type

University, hospital or other

Conditions

Recurrent Grade 1 Follicular Lymphoma; Recurrent Grade 2 Follicular Lymphoma; Recurrent Grade 3a Follicular Lymphoma; Refractory Grade 1 Follicular Lymphoma; Refractory Grade 2 Follicular Lymphoma; Refractory Grade 3a Follicular Lymphoma

Interventions

Biospecimen Collection; Bone Marrow Biopsy; Computed Tomography; Epcoritamab; Positron Emission Tomography; Tazemetostat

Participants

33 (planned, not actual)

Sites

2

Countries

United States

Trials that died the same way

• The Role of Post-traumatic Inhibition of the Innate and Adaptive Immune System in the Development of Infectious Complications in Severely Injured Patients
  “Interim analysis provided enough data” (80% match in meaning)
• Liberty Analyzer WBC System: Reference Interval Study
  “For interim analysis.” (76% match in meaning)
• Somatostatin Analogues With Perioperative Antibiotics Versus Prolonged Antibiotics
  “study paused for interim analysis” (75% match in meaning)
• ICVT in HPV-induced Genital Lesions of Immunocompromised and Immunocompetent Patients
  “Lack of effect in interim analysis” (74% match in meaning)
• RCT of Mobile Apps & FitBit v. Usual Care
  “Study is paused for interim analysis.” (72% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.